Literature DB >> 16219677

CREB-binding protein regulates apoptosis and growth of HMECs grown in reconstituted ECM via laminin-5.

Eric C Dietze1, Michelle L Bowie, Krzysztof Mrózek, L Elizabeth Caldwell, Cassandra Neal, Robin J Marjoram, Michelle M Troch, Gregory R Bean, Kazunari K Yokoyama, Catherine A Ibarra, Victoria L Seewaldt.   

Abstract

Interactions between normal mammary epithelial cells and extracellular matrix (ECM) are important for mammary gland homeostasis. Loss of interactions between ECM and normal mammary epithelial cells are thought to be an early event in mammary carcinogenesis. CREB-binding protein (CBP) is an important regulator of proliferation and apoptosis but the role of CBP in ECM signaling is poorly characterized. CBP was suppressed in basal-cytokeratin-positive HMECs (CK5/6+, CK14+, CK8-, CK18-, CK19-). Suppression of CBP resulted in loss of reconstituted ECM-mediated growth control and apoptosis and loss of laminin-5 alpha3-chain expression. Suppression of CBP in normal human mammary epithelial cells (HMECs) resulted in loss of CBP occupancy of the LAMA3A promoter and decreased LAMA3A promoter activity and laminin-5 alpha-3 chain expression. Exogenous expression of CBP in CBP-negative HMECs that have lost reconstituted ECM-mediated growth regulation and apoptosis resulted in (1) CBP occupancy of the LAMA3A promoter, (2) increased LAMA3A activity and laminin-5 alpha3-chain expression, and (3) enhancement of reconstituted ECM-mediated growth regulation and apoptosis. Similarly, suppression of laminin-5 alpha3-chain expression in HMECs resulted in loss of reconstituted ECM-mediated growth control and apoptosis. These observations suggest that loss of CBP in basal-cytokeratin-positive HMECs results in loss of reconstituted ECM-mediated growth control and apoptosis through loss of LAMA3A activity and laminin-5 alpha3-chain expression. Results in these studies may provide insight into early events in basal-type mammary carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16219677     DOI: 10.1242/jcs.02616

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  7 in total

1.  Purification and characterization of recombinant CH3 domain fragment of the CREB-binding protein.

Authors:  Catherine Ibarra Drendall; Quang H Pham; Eric C Dietze
Journal:  Protein Expr Purif       Date:  2009-12-06       Impact factor: 1.650

2.  Immunohistochemical localization of cyclic AMP-responsive element binding protein (CREB)-binding protein in the pig retina during postnatal development.

Authors:  Hanseul Oh; Heechul Kim; Meejung Ahn; Chanwoo Jeong; Jinwoo Jeong; Changjong Moon; Taekyun Shin
Journal:  Anat Cell Biol       Date:  2011-06-30

3.  DBC1 Regulates p53 Stability via Inhibition of CBP-Dependent p53 Polyubiquitination.

Authors:  Oluwatoyin E Akande; Priyadarshan K Damle; Marius Pop; Nicholas E Sherman; Barbara B Szomju; Larisa V Litovchick; Steven R Grossman
Journal:  Cell Rep       Date:  2019-03-19       Impact factor: 9.423

4.  The impact of CBP expression in estrogen receptor-positive breast cancer.

Authors:  Wafaa S Ramadan; Iman M Talaat; Mahmood Y Hachim; Annette Lischka; Timo Gemoll; Raafat El-Awady
Journal:  Clin Epigenetics       Date:  2021-04-07       Impact factor: 6.551

5.  Lacrimal Gland Microenvironment Changes After Obstruction of Lacrimal Gland Ducts.

Authors:  Xin He; Shaopan Wang; Huimin Sun; Hui He; Yalin Shi; Yiming Wu; Han Wu; Zuguo Liu; Jingyi Zhuang; Wei Li
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-03-02       Impact factor: 4.799

Review 6.  Brain extracellular matrix in neurodegeneration.

Authors:  Dafna Bonneh-Barkay; Clayton A Wiley
Journal:  Brain Pathol       Date:  2008-07-25       Impact factor: 6.508

7.  Epidermal growth-factor-induced transcript isoform variation drives mammary cell migration.

Authors:  Wolfgang J Köstler; Amit Zeisel; Cindy Körner; Jonathan M Tsai; Jasmine Jacob-Hirsch; Nir Ben-Chetrit; Kirti Sharma; Hadas Cohen-Dvashi; Assif Yitzhaky; Eric Lader; Ulrich Tschulena; Gideon Rechavi; Eytan Domany; Stefan Wiemann; Yosef Yarden
Journal:  PLoS One       Date:  2013-12-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.